Bodil Elise Thorhauge Als-Nielsen

Medicine & Life Sciences

1. Precursor Cell Lymphoblastic Leukemia-Lymphoma 100%
2. Thioguanine 47%
3. Randomized Controlled Trials 32%
4. Mercaptopurine 31%
5. Child 25%
6. Clarithromycin 25%
7. Asparaginase 23%
8. Coronary Disease 22%
9. Posterior Leukoencephalopathy Syndrome 20%
10. Hepatic Encephalopathy 20%
11. Mortality 19%
12. Meta-Analysis 17%
13. Methotrexate 17%
14. Epidemiologic Studies 17%
15. Therapeutics 16%
16. Systematic Reviews 15%
17. Pediatrics 15%
18. DNA 14%
19. Central Nervous System 13%
20. Aspergillus flavus 12%
21. T-Lymphoid Precursor Cells 12%
22. Seizures 12%
23. liposomal amphotericin B 11%
24. Placebos 11%
25. Cohort Studies 11%
26. Network Meta-Analysis 11%
27. Chlamydophila pneumoniae 11%
28. Disaccharides 11%
29. Thromboembolism 10%
30. Dopamine Agents 10%
31. Antithrombins 10%
32. Hydroxymethylglutaryl-CoA Reductase Inhibitors 10%
33. B-Lymphoid Precursor Cells 10%
34. Near-Infrared Spectroscopy 10%
35. Aspergillosis 10%
36. Polyethylene 9%
37. Venous Thromboembolism 9%
38. Recurrence 8%
39. Hematology 8%
40. Young Adult 8%
41. Multicenter Studies 8%
42. Nucleotides 8%
43. Brain Injuries 8%
44. Premature Infants 8%
45. Physicians 8%
46. Disease-Free Survival 8%
47. Immunoglobulin A 7%
48. Confidence Intervals 7%
49. Tablets 7%
50. Leukemia 7%